Option News Today — September 8, 2026

The markets are experiencing a wave of volatility today, driven by a combination of disappointing news from the pharmaceutical and technology sectors. Novartis, a major player in the pharmaceutical industry, has seen its stock price plummet by 9% after the company announced setbacks in three of its drug trials. This significant decline is likely to have a ripple effect on the broader healthcare sector, and option traders will be closely watching the stock's movement to gauge the potential impact on related assets. Meanwhile, in the technology space, Nvidia supplier Wistron's decision to launch a $1.5 billion global stock sale has led to a decline in its share price, which may have implications for the semiconductor industry as a whole.

The tech sector is also abuzz with comments from former President Donald Trump, who has claimed to have generated 'hundreds of billions of dollars' in stock gains for the US through his policies. While the veracity of these claims is unclear, they are likely to spark debate and potentially influence market sentiment. As option traders navigate these developments, they will need to consider the potential risks and opportunities arising from these events. With the pharmaceutical and technology sectors experiencing significant movements, option traders will be closely monitoring the situation to identify potential trading opportunities and manage their risk exposure. The intersection of these stories will be crucial to watch, as it may have a significant impact on the overall market direction and volatility.

Today's signal:
• Pharma major Novartis falls 9% after three drug trial setbacks (cnbc.com)
• Nvidia supplier Wistron's shares drop after it announces $1.5 billion global stock sale (cnbc.com)
• Trump says he's made 'Hundreds of Billions of Dollars on Stocks' for the U.S., in stream of AI posts (cnbc.com)